Dawnrays Pharmaceutical (Holdings) Ltd 02348
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 1.19
- Day Range
- HKD 1.16–1.21
- 52-Week Range
- HKD 0.98–1.40
- Bid/Ask
- HKD 1.18 / HKD 1.20
- Market Cap
- HKD 1.77 Bil
- Volume/Avg
- 452,000 / 309,963
Key Statistics
- Price/Earnings (Normalized)
- 5.05
- Price/Sales
- 1.40
- Dividend Yield (Trailing)
- 7.40%
- Dividend Yield (Forward)
- 7.40%
- Total Yield
- 7.40%
Company Profile
Dawnrays Pharmaceutical (Holdings) Ltd is a drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as a component of its international strategies. The company is open to exploring potential acquisitions as a component of its overall growth strategy.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,143
- Website
- https://www.dawnrays.com
Comparables
Valuation
|
Metric
|
02348
|
02877
|
01672
|
|---|---|---|---|
Price/Earnings (Normalized) | 5.05 | 6.53 | — |
Price/Book Value | 0.57 | 0.91 | 0.53 |
Price/Sales | 1.40 | 1.39 | 22.47 |
Price/Cash Flow | 5.12 | 6.14 | — |
Price/Earnings
02348
02877
01672
Financial Strength
|
Metric
|
02348
|
02877
|
01672
|
|---|---|---|---|
Quick Ratio | 2.07 | 2.97 | 16.51 |
Current Ratio | 2.59 | 3.35 | 16.58 |
Interest Coverage | 1,084.97 | 419.36 | −1,693.40 |
Quick Ratio
02348
02877
01672
Profitability
|
Metric
|
02348
|
02877
|
01672
|
|---|---|---|---|
Return on Assets (Normalized) | 11.64% | 10.83% | −5.34% |
Return on Equity (Normalized) | 15.46% | 13.16% | −5.59% |
Return on Invested Capital (Normalized) | 14.62% | 12.66% | −9.56% |
Return on Assets
02348
02877
01672
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fcpjcnqxg | Mwcp | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Wfcxhbdny | Nbrxvy | $69.8 Bil | |
HLN
| Haleon PLC ADR | Ppxpgtgkn | Rcth | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jbtvvvbmh | Kmyp | $14.6 Bil | |
VTRS
| Viatris Inc | Fslhgzsv | Mhfb | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Vqhbpqvt | Rfrpt | $12.6 Bil | |
CTLT
| Catalent Inc | Chccmlqn | Hgtkhm | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Rkwxjdhrw | Mnrmm | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Zzhyncnq | Rmnx | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hyxkqqbt | Hmfyn | $3.6 Bil |